Blue Square Asset Management’s Novartis NVS Stock Holding History

Blue Square Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.77M	Sell	24,082 -46	-0.2%	-$6.9K	1.53%	23
2026 Q1	$3.69M	Buy	24,128 +315	+1%	+$48.3K	1.75%	21
2025 Q4	$3.28M	Sell	23,813 -427	-2%	-$55.9K	1.46%	27
2025 Q3	$3.11M	Sell	24,240 -43	-0.2%	-$5.25K	1.36%	29
2025 Q2	$2.94M	Buy	24,283 +3,089	+15%	+$348K	1.38%	29
2025 Q1	$2.36M	Sell	21,194 -343	-2%	-$36.5K	1.27%	28
2024 Q4	$2.1M	Buy	21,537 +427	+2%	+$45.5K	1.04%	33
2024 Q3	$2.43M	Buy	21,110 +426	+2%	+$48.3K	1.3%	25
2024 Q2	$2.2M	Buy	20,684 +1,744	+9%	+$175K	1.28%	27
2024 Q1	$1.83M	Buy	18,940 +8,285	+78%	+$849K	1.22%	28
2023 Q4	$1.08M	Buy	10,655 +2,226	+26%	+$215K	0.72%	44
2023 Q3	$859K	Sell	8,429 -1,262	-13%	-$128K	0.63%	45
2023 Q2	$978K	Buy	9,691 +1,878	+24%	+$188K	0.7%	48
2023 Q1	$719K	Buy	+7,813	New	+$682K	0.47%	31
2020 Q3	–	Sell	-705	Closed	-$62K	–	150
2020 Q2	$62K	Buy	+705	New	+$60.9K	0.04%	117

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Blue Square Asset Management's NVS Position: Q2 2026 in Review

Blue Square Asset Management reduced its Novartis (NVS) stake by 0.19% in Q2 2026, selling an estimated $6.9K and leaving 24,082 shares worth $3.77M. The position accounts for 1.53% of the portfolio, ranked #23.

Blue Square Asset Management first reported a position in NVS in Q2 2020 and has held it in 15 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Blue Square Asset Management held 24,082 shares of Novartis worth $3.77M as of Q2 2026.
Blue Square Asset Management sold 46 Novartis shares in Q2 2026, an estimated $6.9K.
Novartis made up 1.53% of Blue Square Asset Management's portfolio in Q2 2026, its #23 holding.
Blue Square Asset Management first reported a position in Novartis in Q2 2020 and has held it in 15 quarters since.
1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Blue Square Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.